Showing results (1201-1210 of 1,611) with videos related to

Sort By:
Pageof 162
JAMA Oncology|July 31, 2015
Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal CarcinomaEleni M Rettig, Alicia Wentz, Marshall R Posner, et al.
JAMA Oncology|April 22, 2016
Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab: A Secondary Analysis of the HERA TrialSherene Loi, Urania Dafni, Dimitris Karlis, et al.
JAMA Oncology|April 22, 2016
Cardiovascular Disease After Aromatase Inhibitor UseReina Haque, Jiaxiao Shi, Joanne E Schottinger, et al.
JAMA Oncology|April 22, 2016
Prognostic and Predictive Value in KRAS in Non-Small-Cell Lung Cancer: A ReviewKevin Wood, Thomas Hensing, Raeva Malik, et al.
JAMA Oncology|November 12, 2015
Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNAKasmintan A Schrader, Donavan T Cheng, Vijai Joseph, et al.
JAMA Oncology|March 12, 2016
The Scientific Impact of Positive and Negative Phase 3 Cancer Clinical TrialsJoseph M Unger, William E Barlow, Scott D Ramsey, et al.
JAMA Oncology|March 5, 2016
Population-wide Impact of Long-term Use of Aspirin and the Risk for CancerYin Cao, Reiko Nishihara, Kana Wu, et al.
JAMA Oncology|March 5, 2016
Oncologic Drugs Advisory Committee Recommendations and Approval of Cancer Drugs by the US Food and Drug AdministrationAriadna Tibau, Alberto Ocana, Geòrgia Anguera, et al.
JAMA Oncology|September 4, 2015
Agent Orange Exposure and Monoclonal Gammopathy of Undetermined Significance: An Operation Ranch Hand Veteran Cohort StudyOla Landgren, Youn K Shim, Joel Michalek, et al.
JAMA Oncology|January 16, 2016
Prognostic Effect of BRAF and KRAS Mutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab: A Post Hoc Analysis of the PETACC-8 TrialJulien Taieb, Aziz Zaanan, Karine Le Malicot, et al.
Pageof 162